111 related articles for article (PubMed ID: 785946)
1. Synergistic effect of alloantibodies or F(ab')2 and prednisone on murine split heart allograft survival.
Schilling W; Svehag SE
Acta Pathol Microbiol Scand C; 1976 Aug; 84(4):325-32. PubMed ID: 785946
[TBL] [Abstract][Full Text] [Related]
2. Synergism between alloantibodies or F(ab') 2 and prednisone in the survival of murine split heart allografts.
Svehag SE; Schilling W
Transplantation; 1973 Mar; 15(3):344-6. PubMed ID: 4576044
[No Abstract] [Full Text] [Related]
3. Prolonged survival of renal allografts in outbred rabbits treated with donor specific F(ab')2 alloantibody.
Sutherland DE; Howard RJ; Dombrovskis S; Najarian JS
Ann Surg; 1974 Dec; 180(6):857-63. PubMed ID: 4611361
[TBL] [Abstract][Full Text] [Related]
4. Prolonged survival of corneal allografts incubated in alloantibody fragments.
Gebhardt BM; Varnell ED; Kaufman HE
Transplantation; 1999 Feb; 67(4):594-9. PubMed ID: 10071033
[TBL] [Abstract][Full Text] [Related]
5. Passive enhancement of mouse skin allografts by alloantibodies is Fc dependent.
Capel PJ; Tamboer WP; de Waal RM; Jansen JL; Koene RA
J Immunol; 1979 Feb; 122(2):421-5. PubMed ID: 368240
[TBL] [Abstract][Full Text] [Related]
6. Idarubicin-145-2C11-F(ab')2 promotes peripheral tolerance and reduces chronic vascular disease in mouse cardiac allografts.
Han WR; Murray-Segal LJ; Gershenzon A; Zhang JG; Hodder AN; Pietersz GA; Mottram PL
Transpl Immunol; 1999 Dec; 7(4):207-13. PubMed ID: 10638833
[TBL] [Abstract][Full Text] [Related]
7. Immunological enhancement of a murine tumor allograft by passive alloantibody IgG and F(ab')2.
Kaliss N; Sinclair NR; Cantrell JL
Eur J Immunol; 1976 Jan; 6(1):38-42. PubMed ID: 971718
[TBL] [Abstract][Full Text] [Related]
8. Hyperimmune F(ab') 2 antibody: role in canine hyperacute renal allograft rejection.
Habal MB; Kobayashi K; Busch GJ; Birtch AG
J Surg Res; 1972 Nov; 13(5):228-31. PubMed ID: 4117988
[No Abstract] [Full Text] [Related]
9. Passive enhancement of mouse tumor allografts by alloantibodies is Fc-dependent.
de Waal RM; Cornelissen IM; Capel PJ; Koene RA
J Immunol; 1979 Sep; 123(3):1353-5. PubMed ID: 469254
[TBL] [Abstract][Full Text] [Related]
10. The protective effect of F(ab') 2 and succinylated IgG in the early treatment of hyperacute rejection in the primate.
Habal MB; Carpenter CB; Kobayashi K; Bush GJ; Misra M; Birtch AG
Transplant Proc; 1973 Mar; 5(1):601-6. PubMed ID: 4633093
[No Abstract] [Full Text] [Related]
11. A quantitative comparison of whole antibody and F(ab')2 in kidney allograft enhancement.
Winearls CG; Fabre JW; Millard PR; Morris PJ
Transplantation; 1979 Jul; 28(1):36-9. PubMed ID: 377591
[TBL] [Abstract][Full Text] [Related]
12. Biodistribution of an anti-interleukin 2 receptor monoclonal antibody in rat recipients of a heart allograft, and its use as a rejection marker in gamma scintigraphy.
Thedrez P; Paineau J; Jacques Y; Chatal JF; Pelegrin A; Bouchaud C; Soulillou JP
Transplantation; 1989 Sep; 48(3):367-71. PubMed ID: 2675394
[TBL] [Abstract][Full Text] [Related]
13. Pre- and posttransplantation allosensitization in heart allograft recipients: major impact of de novo alloantibody production on allograft survival.
Ho EK; Vlad G; Vasilescu ER; de la Torre L; Colovai AI; Burke E; Deng M; Schwartz J; Marboe C; Mancini D; Opelz G; Suciu-Foca N
Hum Immunol; 2011 Jan; 72(1):5-10. PubMed ID: 20971146
[TBL] [Abstract][Full Text] [Related]
14. The use of human F(ab') 2 fragments as blocking agents in the mixed lymphocyte reaction.
Hornung MO; Layne E; McDonald JC
J Immunol; 1971 Oct; 107(4):979-84. PubMed ID: 4999263
[No Abstract] [Full Text] [Related]
15. Passive enhancement of canine renal allografts with polyspecific F(ab')2 fragments.
Wren SF; Martins AC; Von Haefen U; Busch GJ; Katske GE; Koppenheffer TL; Shaipanich T; Wilson RE
Surgery; 1974 Jul; 76(1):112-20. PubMed ID: 4135410
[No Abstract] [Full Text] [Related]
16. Effects of antibody reactivity to major histocompatibility complex (MHC) and non-MHC alloantigens on graft endothelial cells in heart allograft rejection.
Derhaag JG; Duijvestijn AM; Damoiseaux JG; van Breda Vriesman PJ
Transplantation; 2000 May; 69(9):1899-906. PubMed ID: 10830229
[TBL] [Abstract][Full Text] [Related]
17. Anti-CD3 F(ab')2 fragments are immunosuppressive in vivo without evoking either the strong humoral response or morbidity associated with whole mAb.
Hirsch R; Bluestone JA; DeNenno L; Gress RE
Transplantation; 1990 Jun; 49(6):1117-23. PubMed ID: 2141740
[TBL] [Abstract][Full Text] [Related]
18. Protection of heart and rejection of lymphocyte allografts from the same donor in recipients of donor-specific transfusions.
Jaskłowska-Englisz M; Olszewski WL; Maksymowicz M; Ziółkowska A
Ann Transplant; 1998; 3(1):28-33. PubMed ID: 9869895
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of action of anti-IL-2R monoclonal antibodies. ART-18 prolongs cardiac allograft survival in rats by elimination of IL-2R+ mononuclear cells.
Tanaka K; Hancock WW; Osawa H; Stunkel KG; Alberghini TV; Diamantstein T; Tilney NL; Kupiec-Weglinski JW
J Immunol; 1989 Nov; 143(9):2873-9. PubMed ID: 2530281
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of islet allograft survival in mice treated with MHC class I specific F(ab')2 alloantibody.
Osorio RW; Ascher NL; Melzer JS; Stock PG
Transplant Proc; 1994 Apr; 26(2):749. PubMed ID: 8171642
[No Abstract] [Full Text] [Related]
[Next] [New Search]
